Stock ATXI AVENUE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Avenue Therapeutics, Inc.

Equities

ATXI

US05360L4032

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
6.2 USD -29.34% Intraday chart for Avenue Therapeutics, Inc. -36.41% -48.65%
03-18 Avenue Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-22 Avenue Therapeutics, Inc. Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in A Translational Model of Absence Epilepsy CI

Chart calendar Avenue Therapeutics, Inc.

578ed2901.yCMyY3MJDF652TTmNX4AUb7jBbG0ckKvrjVIbBvhBeU.m3t3NAloZyjOtWTQZjB5BPfWT_XiGhjr8UMZQU_RXdavfHY3BV17DubsBA~fac67ca281e8118640f2438d855d4302

Upcoming events on Avenue Therapeutics, Inc.

12/05/2024 Q1 2024 Earnings Release (Projected)
11/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
24/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Avenue Therapeutics, Inc.

04/04/2024 16:00 Investor Meeting - Key Opinion Leader
18/03/2024 20:05 Q4 2023 Earnings Release
13/03/2024 17:30 American Society for Experimental Neurotherapeutics Meeting
18/01/2024 15:00 Sidoti Micro Cap Investor Conference
02/12/2023 17:00 American Epilepsy Society Meeting - Poster Number :444
30/11/2023 American Epilepsy Society Meeting
13/11/2023 21:05 Q3 2023 Earnings Release
11/09/2023 12:00 H.C. Wainwright Global Investment Conference
10/08/2023 21:15 Q2 2023 Earnings Release
22/06/2023 14:30 Annual General Meeting
12/05/2023 13:30 Q1 2023 Earnings Release
04/05/2023 21:00 Aegis Capital Virtual Conference
30/03/2023 21:01 Q4 2022 Earnings Release
30/01/2023 20:00 Annual General Meeting
10/11/2022 21:10 Q3 2022 Earnings Release
14/08/2022 Interim 2022 Earnings Release
23/02/2022 19:30 Aegis Capital Virtual Summit
16/12/2021 14:00 Annual General Meeting
12/10/2020 13:30 IV Tramadol CRL Update Call
14/08/2020 12:30 Interim 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-26,3
-25,5
-2.92%		-5,21
-5,41
3.59%		-8,04
-4,83
-66.49%		-14,5
-10,5
-37.95%
-13,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-25,9
-25,2
-2.76%		-5,15
-5,12
-0.52%		0,00
0,00
- 		-10,5
-9,58
-9.54%
-13,3

Net income
Million USD		Released
Forecast
Spread 		-25,9
-25,2
-2.76%		-5,15
-5,12
-0.52%		-3,55
-4,83
26.4%		-10,4
-9,37
-10.69%
-13,3

EPS
USD		Released
Forecast
Spread 		-1 856
-1 800
-3.12%		-349
-349
0%		-122
-159
23.11%		-73,5
-73,1
-0.51%
-30,8

Announcement Date30/03/2031/03/2130/03/2318/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread


-3,91
-0,70
-458.86%		-6,43
-0,90
-614.33%		-3,92
-1,00
-292.3%		-2,07
-1,50
-37.87%		-2,12
-2,35
9.83%
-3,06


-3,19


-3,46


-3,59

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread














0,62
-2,70
122.85%
-3,06


-3,19


-3,46


-3,59

Net income
Million USD		Released
Forecast
Spread 		-0,66


0,58
-0,70
182.26%		-7,54
-0,90
-738.26%		-4,01
-1,73
-131.75%		0,53
-2,23
123.59%		0,64
-2,48
125.76%
-3,06


-3,19


-3,46


-3,59

EPS
USD		Released
Forecast
Spread 		-33,8


92,3
-11,3
920%		-103
-9,75
-953.85%		-39,0
-21,8
-79.31%		4,50
-19,5
123.08%		42,0
-7,50
660%
-9,00


-7,50


-8,25


-6,75

Announcement Date10/11/2230/03/2310/05/2310/08/2313/11/2318/03/24----

Upcoming sector events for Avenue Therapeutics, Inc.

28/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
28/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
30/04/2024 21:05 EXELIXIS, INC.: Q1 2024 Earnings Release
30/04/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
30/04/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Avenue Therapeutics, Inc.

25/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
25/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
25/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
25/04/2024 21:05 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 11:30 SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
24/04/2024 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
24/04/2024 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ATXI Stock
  4. Calendar Avenue Therapeutics, Inc.